Sorrento Therapeutics Inc (SRNE)

[runcaly]

SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming panel at the Longwood Healthcare Leaders Winter Conference:

January 6th at 11:50 am PT / 2:50 pm ET 
HOW M&A SPURS INNOVATION 
Mark Enyedy, CEO, ImmunoGen; Henry Ji, CEO, Sorrento Therapeutics; Rachna Khosla, SVP, BD, Amgen; Stuart Mackey, Global Head, BD, Daiichi Sankyo
Moderator: Chad Shear, Principal, Fish & Richardson

Conference information: January 6-7, 2022 Webconference | Longwood Healthcare Leaders

Longwood Healthcare Leaders meetings are invitation-only forums typically held at leading academic institutions.  Biopharma CEOs, heads of R&D, academic researchers, and healthcare investors join off-the-record discussions that generate new company ideas and approaches for Longwood Fund and members of our biopharma ecosystem, creating strategic business opportunities to advance the industry and bring important medicines to patients in need.